Background and Objectives A considerable proportion of patients who require mitral valve MV replacement present with a coexisting pathology of the aortic valve AV . However, combined AV and MV replacement is associated with increased operative risk and lower long-term survival rates than MV replacement MVR alone. Little is known concerning the natural history of AV disease in patients undergoing MV surgery. The purpose of this study was to analyze the long-term clinical outcome and requirements for subsequent AV replacement AVR in patients with mild to moderate AV disease at the time of MV surgery. Materials and Method One hundred forty-one patients 97 female, mean age 43 years with mild to moderate AV disease and severe rheumatic MV disease were treated with MV surgery. The patients were followed for an average period of 8 3 years range 1 16 following MV surgery. Primary outcomes death and subsequent AVR were evaluated. Results At the time of MV surgery, 104 patients 73.8% had mild aortic regurgitation AR , 37 patients 26.2% moderate AR, 5 patients 3.5% mild aortic stenosis AS and 2 patients 1.4% moderate AS. At the end of the follow-up period only one patient had severe AR. Eight patients 5.7% died during the follow-up, and four patients 2.8% were treated with AVR after a mean period of 9 years. A survival analysis with using the Kaplan-Meier method revealed a 10-year survival rate of 95.5% and a 10-year event free survival rate of 93.6%. Conclusion In most patients with mild to moderate rheumatic AV disease at the time of MV surgery, subsequent AVR is rarely required after a long follow-up period. This data may support a decision not to recommend prophylactic AVR at the time of MV surgery in these patients. Korean Circulation J

